With a $1.92 million grant, the Leon Levy Foundation is renewing its fellowship in neuroscience through 2019, ensuring that more early-career physicians and scientists can pursue their innovative research.
Treating terminally ill cancer patients with chemotherapy in the months or weeks before their deaths was not found to improve patients' quality of life and may actually do more harm than good.
Dr. Karla Ballman has been named chief of the Division of Biostatics and Epidemiology in the Department of Healthcare Policy and Research at Weill Cornell Medical College.
Patients who develop an infection of the heart valves have an elevated risk of stroke beginning four months before and up to five months after diagnosis -- a period significantly longer than previously reported.
A non-invasive scan used to determine the extent of plaque buildup in the heart accurately predicts the likelihood of heart attack or death over a 15-year period.
Investigators have discovered the precise molecular steps that enable immune cells implicated in certain forms of asthma and allergy to develop and survive in the body.
A simple algorithm accurately predicts whether a stable patient is likely to suffer from coronary artery disease or die of a heart attack in the next three years.
Cognitive behavioral therapy is the most consistently effective way to manage symptoms tied to panic disorder, though another less-structured treatment also shows promise.
In the increasingly competitive market for postdoctoral funding, the Revson Fellowship provided funds for both Drs. Wendy Beguelin and Kate Meyer, which allowed them to do more than just continue their research.
Six young scientists at Memorial Sloan Kettering Cancer Center, Rockefeller University, and Weill Cornell Medical College have been named the inaugural winners of a new prize established to recognize postdoctoral investigators in the life sciences.
